Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 24 Jun | 97.40 |
-0.85 (-0.87%) |
OPEN
96.05 |
HIGH
99.70 |
LOW
96.05 |
| NSE 00:00 | 24 Jun | 98.95 |
1.35 (1.38%) |
OPEN
99.45 |
HIGH
99.50 |
LOW
98.00 |
| OPEN | 96.05 |
| PREVIOUS CLOSE | 98.25 |
| VOLUME | 6551 |
| 52-Week high | 137.95 |
| 52-Week low | 39.00 |
| P/E | 249.74 |
| Mkt Cap.(Rs cr) | 144 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bal Pharma Ltd. (BALPHARMA) - Announcements
-
Bal Pharma Ltd Board to consider Dividend
15/06/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Intimation for Board Meeting Intimation
15/06/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
24/05/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Demise
21/05/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Initial Disclosure -Large Corporate
30/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Clarification On Price Movement.
26/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Clarification sought from Bal Pharma Ltd
26/04/2021 | bse
-
Bal Pharma Ltd Compliance With Regulation 40(9) Of SEBI(LODR) Regulations2015.
21/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
19/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Shareholding for the Period Ended March 31 2021
14/04/2021 | bse
-
Bal Pharma Ltd Compliance With Regulation 7(3) Of SEBI(LODR) Regulations
12/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
05/04/2021 | bse
-
Bal Pharma Ltd Disclosure Reg Large Corporate.
02/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Closure of Trading Window
30/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Acquisition
23/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
22/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
22/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Outcome Of The Board Meeting
17/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Credit Rating
15/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Intimation for Allotment Of Shares On Conversion Of Warrants
09/03/2021 | bse |
Downlaod PDF
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
